A recent meta-analysis suggested that there is insufficient evidence to support the use of CRP, procalcitonin, or IL6 in maternal blood for HCA diagnosis in PPROM (Etyang et al., 2020). The gene discussed is CRP; the disease is preterm premature rupture of the membranes.